XML 149 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2023 and 2022:

 

   Level 1   Level 2   Level 3 
   Fair Value Measurements at December 31, 2023 
   Level 1   Level 2   Level 3 
Assets            
Cash  $657,789   $-   $- 
Right-of-use-asset   -    -    147,228 
Notes receivable   -    384,628    - 
Total assets   657,789    384,628    147,228 
Liabilities               
Notes payable   -    235,000    - 
Lease liability   -    -    131,930 
Total liabilities   -    235,000    131,930 
Total assets and liabilities  $657,789   $149,628   $15,298 

 

   Level 1   Level 2   Level 3 
   Fair Value Measurements at December 31, 2022 
   Level 1   Level 2   Level 3 
Assets            
Cash  $312,697   $-   $- 
Cash, restricted   235,750    -    - 
Notes receivable   -    384,628    - 
Total assets   548,447    384,628    - 
Liabilities               
Convertible notes payable, related parties   -    -    140,000 
Convertible notes payable   -    -    4,919,191 
Notes payable   -    2,284,000    - 
Revolving line of credit   -    91,541    - 
Total liabilities   -    2,376,041    5,059,191 
Total assets and liabilities  $548,447   $(1,991,413)  $(5,059,191)